Blood screening refers to the process of testing blood for infectious agents that can transmit diseases. It is an important part of the safety of blood transfusion. All blood samples, donations and components should be correctly labeled to ensure correct identification throughout the screening process. The purpose of blood screening is to detect markers of infection and prevent the release of infected blood and blood components for clinical use.
Quality-assured screening of all donated blood for transfusion-transmissible infections (TTIs), including HIV, HBV, HCV and syphilis, is one of the strategies recommended by the World Health Organization (WHO) to provide safe blood and blood products and is an important part of every national blood program. Daan Gene’s detection kit, combined with NAT detection technology, can effectively prevent the transmission of viral diseases through blood transfusion and minimize the risk of blood transfusion-transmitted diseases.